What Are the Best CDMOs in Massachusetts?
Massachusetts is home to some of the most advanced contract development and manufacturing organizations (CDMOs) in the world. The best CDMOs in Massachusetts for your project depend on your modality (biologics, cell & gene therapy, small molecule), development stage (preclinical, clinical, commercial), and capacity needs.
Top Massachusetts CDMOs include:
- Boston Institute of Biotechnology (BIB) — Biologics, mAbs, ADCs
- STC Biologics — Antibody development, cell line engineering
- Recipharm Advanced Bio — Gene therapy, viral vectors
- WuXi Biologics (Worcester) — Large-scale biologics, global supply
- Genezen — AAV gene therapy, plasmid DNA
- Revolution Biomanufacturing — Flexible biologics, emerging modalities
- Resilience (Watertown) — Cell & gene therapy, mRNA
- National Resilience — Advanced therapies, tech-enabled manufacturing
This guide is designed to help pharma and biotech decision-makers evaluate Massachusetts CDMOs based on capabilities, capacity, and fit, not paid placement.
Curated Resource
Updated May 2026 • No Paid Placements
Want Your CDMO on This List?
This guide is read by pharma and biotech sponsors actively searching for manufacturing partners. If your CDMO operates in Massachusetts and meets our criteria, we’ll add you — no fee, no sponsorship required.
435%
Traffic Growth
3x
Inbound RFPs
~$1B
Capacity Growth
Amanda Pacheco
Director of Client Strategy
Why Massachusetts? The CDMO Advantage
Massachusetts isn’t just a biotech hub, it’s the epicenter of advanced drug development and manufacturing in the United States. According to MassBio’s 2025 Industry Snapshot, the state is home to over 1,000 biopharma companies and more than 90,000 life sciences employees.
Key advantages of Massachusetts CDMOs:
- Proximity to innovation: Direct access to Harvard, MIT, and the Longwood Medical Area — the world’s densest concentration of biomedical research.
- Talent density: The highest concentration of PhD-level scientists and bioprocess engineers in North America.
- Regulatory expertise: Many Massachusetts CDMOs have deep FDA relationships and experience with complex INDs, BLAs, and NDAs.
- Modality breadth: From monoclonal antibodies to AAV gene therapies to mRNA, Massachusetts CDMOs cover the full spectrum of advanced modalities.
“Massachusetts CDMOs are uniquely positioned to support sponsors from early discovery through commercial launch, often within a single campus.” — Bob Generale, Percepture
How We Evaluated Massachusetts CDMOs
This guide is not a paid ranking. We compiled this list using publicly available data, industry directories, and direct outreach. Our methodology prioritizes:
- Modality coverage: Does the CDMO support your drug type (biologics, cell & gene, small molecule)?
- Development stage: Can they support preclinical, clinical, and/or commercial manufacturing?
- Capacity & scale: Do they have the infrastructure for your batch size and timeline?
- Regulatory track record: Have they successfully supported FDA filings?
- Geographic footprint: Are they headquartered or operating in Massachusetts?
Transparency note: Percepture is a marketing agency serving CDMOs and pharma companies. We do not accept payment for inclusion in this guide. If you’re a CDMO and want to update your listing, contact us here.
Massachusetts CDMO Comparison Table
| CDMO | Location | Modalities | Stage | Capacity | Website |
| Boston Institute of Biotechnology (BIB) | Cambridge, MA | Biologics, mAbs, ADCs | Preclinical–Commercial | Mid-scale | bostoniob.com |
| STC Biologics | Cambridge, MA | Antibody, cell line | Preclinical–Phase III | Mid-scale | stcbiologics.com |
| Recipharm Advanced Bio | Watertown, MA | Gene therapy, viral vectors | Preclinical–Commercial | Large-scale | recipharm.com |
| WuXi Biologics | Worcester, MA | Biologics, mAbs | Clinical–Commercial | Large-scale | wuxibiologics.com |
| Genezen | Charlestown, MA | AAV, plasmid DNA | Preclinical–Phase III | Mid-scale | genezen.com |
| Revolution Biomanufacturing | Woburn, MA | Biologics, emerging modalities | Preclinical–Phase II | Flexible | revolutionbio.com |
| Resilience | Watertown, MA | Cell & gene, mRNA | Clinical–Commercial | Large-scale | resilience.com |
| National Resilience | Boston, MA | Advanced therapies | Clinical–Commercial | Large-scale | resilience.com |
Table updated May 2026. For corrections or additions, contact Percepture.
🔬 Free Diagnostic for CDMOs
Being on the List Is Step One.
Being Top of Mind Is the Goal.
When sponsors search “CDMO Massachusetts” or ask ChatGPT for recommendations, does your company appear? Our CDMO Visibility Audit shows you exactly where you rank — in Google, AI search, and industry directories — and what it takes to move up.
What You’ll Receive:
- Google SERP Position — Where you rank for 10+ high-intent CDMO keywords
- AI Search Presence — Are you cited by ChatGPT, Perplexity, Claude?
- Competitor Gap Analysis — How you compare to 3 direct competitors
- Quick-Win Recommendations — 3 actions to improve visibility in 90 days
Christine Rodi
VP of Strategy
CDMO Profiles: What Each Massachusetts CDMO Does Best
Boston Institute of Biotechnology (BIB)
Best for: Emerging biotech sponsors seeking end-to-end biologics support.
Capabilities: Cell line development, upstream/downstream process development, analytical services, cGMP manufacturing.
Why sponsors choose BIB: Fast timelines, flexible batch sizes, strong regulatory support.
STC Biologics
Best for: Antibody-focused programs, early-stage sponsors.
Capabilities: Antibody discovery, cell line engineering, process development, clinical manufacturing.
Why sponsors choose STC: Deep antibody expertise, rapid turnaround, Cambridge location.
Recipharm Advanced Bio
Best for: Gene therapy sponsors needing viral vector manufacturing.
Capabilities: Lentiviral, AAV, and adenoviral vector production; plasmid DNA; fill-finish.
Why sponsors choose Recipharm: Global scale, regulatory track record, integrated supply chain.
WuXi Biologics (Worcester)
Best for: Large-scale biologics, global clinical and commercial supply.
Capabilities: Mammalian cell culture, microbial fermentation, ADCs, bispecifics.
Why sponsors choose WuXi: Massive capacity, global footprint, speed to IND.
Genezen
Best for: AAV gene therapy, plasmid DNA manufacturing.
Capabilities: AAV production, plasmid DNA, analytical development, process optimization.
Why sponsors choose Genezen: Gene therapy specialization, flexible scale, Boston-area location.
Revolution Biomanufacturing
Best for: Emerging modalities, flexible manufacturing.
Capabilities: Biologics, cell culture, process development, tech transfer.
Why sponsors choose Revolution: Agility, emerging modality expertise, sponsor-friendly terms.
Resilience
Best for: Cell & gene therapy, mRNA, advanced therapies.
Capabilities: Viral vector, mRNA, cell therapy, fill-finish, commercial manufacturing.
Why sponsors choose Resilience: Tech-enabled manufacturing, large-scale capacity, innovation focus.
How to Choose the Right Massachusetts CDMO
Selecting a CDMO is one of the most consequential decisions a pharma or biotech company will make. Here’s a framework for evaluating Massachusetts CDMOs:
1. Match Modality to Capability
Not all CDMOs support all modalities. If you’re developing an AAV gene therapy, don’t waste time with a small-molecule-only CDMO. Use the table above to filter by modality.
2. Align Development Stage
Some CDMOs specialize in early-stage (preclinical, Phase I), while others focus on commercial-scale manufacturing. Make sure your CDMO can support your current stage and your next stage.
3. Evaluate Capacity & Timeline
Capacity constraints are real. Ask about current utilization, lead times, and flexibility. A CDMO with a 12-month waitlist may not be the right fit for a fast-moving program.
4. Assess Regulatory Track Record
Has the CDMO successfully supported FDA filings? Ask for references and case studies. Regulatory missteps can delay your program by years.
5. Consider Location & Logistics
Massachusetts CDMOs offer proximity to Boston’s biotech ecosystem, but logistics matter. If you need global supply, consider CDMOs with international footprints (e.g., WuXi, Recipharm).
The Hidden Cost of Choosing the Wrong CDMO
Choosing the wrong CDMO can cost you more than money. It can cost you time, regulatory standing, and — in the worst cases — your program.
Common CDMO selection mistakes:
- Prioritizing price over capability: The cheapest CDMO is rarely the best fit.
- Ignoring cultural fit: Communication breakdowns cause delays.
- Failing to plan for scale-up: A CDMO that works at Phase I may not work at Phase III.
- Skipping due diligence: Always visit the facility, review quality systems, and check references.
“In our work with CDMO clients, we’ve seen sponsors lose 12–18 months due to poor CDMO selection. The right partner accelerates your program; the wrong one derails it.” — Bob Generale, Percepture
How Percepture Helps CDMOs Get Found
Percepture is a marketing agency specializing in life sciences — including CDMOs, pharma, biotech, and CROs. We help CDMOs:
- Rank higher in Google and AI search for high-intent keywords like “CDMO Massachusetts” and “best CDMOs in Massachusetts.”
- Generate qualified inbound leads from sponsors actively searching for manufacturing partners.
- Build authority and trust through content, PR, and digital strategy.
Proof:
- 435% organic traffic growth for a mid-sized CDMO client (12 months)
- 3x increase in inbound RFP volume for a gene therapy CDMO
- ~$1B in attributed capacity growth across our CDMO portfolio
Ready to Grow Your CDMO’s Pipeline?
Percepture is the marketing agency for life sciences. We help CDMOs rank higher in Google and AI search, generate qualified inbound leads, and win more sponsors.
435%
Organic Traffic Growth
3x
Inbound RFP Volume
~$1B
Attributed Capacity Growth
Amanda Pacheco
Director of Client Strategy
Christine Rodi
VP of Strategy
Frequently Asked Questions: CDMOs in Massachusetts
What is a CDMO?
A CDMO (Contract Development and Manufacturing Organization) is a company that provides drug development and manufacturing services to pharmaceutical and biotech companies. CDMOs handle everything from process development to clinical and commercial manufacturing.
How many CDMOs are in Massachusetts?
Massachusetts is home to dozens of CDMOs, ranging from small, specialized firms to global manufacturing giants. The state’s concentration of biotech companies and research institutions makes it a natural hub for contract manufacturing.
What modalities do Massachusetts CDMOs support?
Massachusetts CDMOs support a wide range of modalities, including:
- Monoclonal antibodies (mAbs)
- Antibody-drug conjugates (ADCs)
- Cell & gene therapies (AAV, lentiviral, CAR-T)
- mRNA and nucleic acid therapies
- Small molecules (select CDMOs)
How do I choose the right CDMO in Massachusetts?
Start by matching your modality and development stage to the CDMO’s capabilities. Evaluate capacity, regulatory track record, and cultural fit. Always conduct site visits and check references before signing a contract.
Is this list paid or sponsored?
No. This guide is not a paid ranking. Percepture compiled this list using publicly available data and industry research. We do not accept payment for inclusion. If you’re a CDMO and want to update your listing, contact us.
Related Resources
- CDMO Marketing: How to Win More Pharma Sponsors
- SEO for CDMOs: The Complete Guide
- How CDMOs Can Win in AI Search (GEO)
- Pharma CDMO Case Study: 435% Traffic Growth
About the Author
Bob Generale is the President of Percepture, a marketing agency specializing in life sciences. Bob has spent 15+ years helping CDMOs, pharma, and biotech companies grow through SEO, content, and digital strategy. He is a frequent speaker and known for being the “Navy Seals of Marketing” and nicknamed the Magician for his ability to earn #1 rankings in 24 hours or make results disappear in a 3 day seo reputation management sprint. Percepture has had a long presence at industry conferences and they are a contributor to the life sciences marketing industy and publications.
Connect with Bob on LinkedIn: Best CDMO SEO Expert
Connect with us today!
This article was last updated in May 2026. For corrections, additions, or to request a CDMO listing update, contact Percepture.
